baber/WOPTO huggingface dataset:
Patent AU-2011223512-B2 (AU)
Title: Filter bypass
Inventor: AJAY KEMAL
IPC: B01D46/00
Filed: 2011-03-04
Granted: 2016-07-21
Abstract: There is describes a filter arrangement (10) for a particle detector (12) for detecting particles in an environment. The particle detector (12) can include one or more sensors (30) for analysing fluid in a detection region to produce sensor output. The filter arrangement (30) includes structure defining flow paths, for conveying fluid from the environment towards the detection region, including a first flow path (22), which includes a filter(26), and a second flow path (24) bypassing the filter(10). There is also provided a mechanism (120B) for controlling relative flow rates of fluid through the first flow path (22) and the second flow path (24) and a controller (32) configured to receive the sensor output corresponding to at least two relative flow rates and apply logic thereto to generate an output indicative of a condition of the filter.
Patent AU-2011241040-B2 (AU)
Title: Vanadia-based DeNOx catalysts and catalyst supports
Inventor: AUGUSTINE STEVE M
IPC: B01J37/03
Filed: 2011-03-09
Granted: 2015-09-17
Abstract: A vanadia-based catalytic composition for reduction of nitrogen oxides includes a titania-based support material; vanadia deposited on the titania-based support material; a primary promoter comprising tungsten oxide, molybdenum oxide or combinations thereof; and an amount of phosphate to achieve a mole ratio of phosphorus to vanadium plus molybdenum of about 0.2:1 or greater. A zirconia, tin or manganese oxide can be added to further inhibit the volatility of molybdenum. Results show low SO
Patent AU-2011253615-B2 (AU)
Title: Compositions and methods for control of insect infestations in plants
Inventor: BAUM JAMES A
IPC: A01H5/00
Filed: 2011-11-23
Granted: 2012-09-13
Abstract: The present invention is directed to controlling pest infestation by inhibiting one or more biological functions in an invertebrate pest. The invention discloses methods and compositions for use in controlling pest infestation by feeding one or more different recombinant double stranded RNA molecules to the pest in order to achieve a reduction in pest infestation through suppression of gene expression. The invention is also directed to methods for making transgenic plants that express the double stranded RNA molecules, and to particular combinations of transgenic pesticidal agents for use in protecting plants from pest infestation.
Patent AU-2011254658-B2 (AU)
Title: Purification of posaconazole and of posaconazole intermediates
Inventor: LANGNER MARTIN
IPC: C07D405/06
Filed: 2011-05-18
Granted: 2016-02-18
Abstract: The present invention relates to a process for the preparation of a hydrogen chloride (HC1) salt of a compound of formula (I) wherein Y
Patent AU-2011265361-B2 (AU)
Title: Woven fabric having composite yarns for endoluminal devices
Inventor: RASMUSSEN ERIK E
IPC: A61F2/06
Filed: 2011-12-20
Granted: 2014-03-06
Abstract: A woven fabric for a low profile implantable medical device includes a plurality of textile strands of a composite yarn aligned in a first direction interlaced with a plurality of textile strands of the composite yarn aligned in a second direction. The composite yarn includes a combination of a first material and a 5 second material. The textile strands have a size between about 10 denier to about 20 denier. The first material has at least one characteristic different from the second material and the second material reacts favorably with blood when placed within an artery.
Patent AU-2011307321-B2 (AU)
Title: Lens with multi-segmented linear meniscus wall
Inventor: PUGH RANDALL B
IPC: G02B3/14
Filed: 2011-09-26
Granted: 2015-04-23
Abstract: The present invention relates generally to an arcuate liquid meniscus lens with a meniscus wall. Some specific embodiments include a liquid meniscus lens with a meniscus wall essentially in the shape of multiple segments of a frustum of a cone. Embodiments may also include a lens of suitable size and shape for inclusion in a contact lens.
Patent AU-2011319747-B2 (AU)
Title: FVIII peptides for immune tolerance induction and immunodiagnostics
Inventor: STEINITZ KATHARINA NORA
IPC: A61P7/04
Filed: 2011-10-27
Granted: 2016-01-07
Abstract: The present invention is related to peptides that can be used to reduce the immune response against FVIII or to induce tolerance to human FVIII in patients with, e.g., hemophilia A. Furthermore, the peptides can be used for immunodiagnostic purposes to detect FVIII- specific CD4
Patent AU-2011326655-B2 (AU)
Title: Presenting actions and providers associated with entities
Inventor: RUBINSTEIN BENJAMIN
IPC: G06F17/30
Filed: 2011-10-30
Granted: 2016-10-27
Abstract: Computer-readable media, computer systems, and computing devices method of facilitating presentation of actions and providers associated with entities. The method includes determining a query intent of a received query. Entity sets having an entity that matches the determined query intent are recognized. Each entity set includes an entity, an action, and a provider. Actions and/or providers associated with the entity that matches the determined query intent are identified. The actions and/or the corresponding providers associated with the entity are provided for integration with a representation of the associated entity on a search results page.
Patent AU-2011369812-B2 (AU)
Title: Filling container and method for storing hazardous waste material
Inventor: BERMUDEZ WALTER GUILLERMO
IPC: G21F9/36
Filed: 2011-06-02
Granted: 2015-07-23
Abstract: The present invention provides systems, methods and devices for storing and/or disposing of hazardous waste material. In some embodiments, the waste material includes nuclear waste such as calcined material. In certain embodiments, the device includes a container having a container body, a filling port configured to couple with a filling nozzle and a filling plug, and an evacuation port having a filter. The evacuation port is configured to couple with an evacuation nozzle and an evacuation plug. In certain embodiments, the method includes (a) adding hazardous waste material via a filling nozzle coupled to a filling port of a container, the container including an evacuation port, (b) evacuating the container during adding of the hazardous waste material via an evacuation nozzle coupled to an evacuation port of the container, (c) sealing the filling port, (d) heating the container, and (e) sealing the evacuation port.
Patent AU-2011376518-B2 (AU)
Title: Method for determining front and rear surfaces for optical patches
Inventor: COLAS PAULINE
IPC: G02C7/02
Filed: 2011-09-06
Granted: 2015-04-30
Abstract: Optical patches are assigned to prescriptions so as to reduce the total number of patch surfaces which are involved. The prescriptions are produced by varying at least one of a front patch surface (S1) and rear patch surface (S2) which are combined to form an optical patch, in accordance with prescription segments. The front patch surfaces (S1) are pseudo-spherical and the rear patch surfaces (S2) are comprised of a Fresnel structure superimposed on a pseudo-spherical base shape.
Patent AU-2012200761-B2 (AU)
Title: Induction of exon skipping in eukaryotic cells
Inventor: VAN OMMEN GARRIT-JAN BOUDEWIJN
IPC: A61K45/00
Filed: 2012-02-09
Granted: 2012-11-15
Abstract: The present invention provides a method for at least in part decreasing the production of an aberrant protein in a cell, said cell comprising pre-mRNA comprising exons coding for said protein, by 5 inducing so-called exon skipping in said cell. Exon-skipping results in mature mRNA that does not contain the skipped exon which leads to an altered product if said exon codes for amino acids. Exon skipping is performed by providing a cell with an agent capable of specifically inhibiting an exon inclusion signal, for instance an exon recognition .0 sequence, of said exon. Said exon inclusion signal can be interfered with by a nucleic acid comprising complementary to a part of said exon. Said nucleic acid, which is also herewith provided, can be used for the preparation of a medicament, for instance for the treatment of an inherited disease.
Patent AU-2012202375-B2 (AU)
Title: Fabric system
Inventor: WALVIUS SUSAN KATHERINE
IPC: D03D11/00
Filed: 2012-04-24
Granted: 2013-11-07
Abstract: Bedding material including a first fabric section manufactured from performance fabric and having a first and second side; and, a second fabric section attached to the first side of the first fabric section. Additionally, a third fabric section can be attached to the second side of the first fabric section. The first fabric section can be attached to the second fabric section through a flatlock stitch. The first fabric section can include a first zone and a second zone wherein the first zone contains different performance properties from the second zone and the first zone can have thermal or moisture wicking properties. WO 2010/037082 PCT/US2009/0587 16 12' f~3gTpgflI
Patent AU-2012217935-B2 (AU)
Title: Facial detection, recognition and bookmarking in videos
Inventor: STEINER MATTHEW S
IPC: G11B27/28
Filed: 2012-02-13
Granted: 2015-09-17
Abstract: Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for facial bookmarking in videos. In one aspect, methods include receiving a digital video comprising video data, processing the video data to detect features indicative of a human face in the digital video, determining, from the video data, a first frame, in which the features indicative of the human face are detected in the digital video, determining first timestamp data corresponding to the first frame, determining, from the video data, a second frame, in which the features indicative of the human face are detected in the digital video, determining second timestamp data corresponding to the second frame, generating an identifier corresponding to the human face, generating a data set including the identifier, the first timestamp data and the second timestamp data, and appending the data set to the video data to provide annotated video data.
Patent AU-2012222348-B2 (AU)
Title: New compositions for treating neurological disorders
Inventor: CHUMAKOV ILYA
IPC: A61K31/64
Filed: 2012-03-01
Granted: 2017-05-25
Abstract: The present invention relates to compositions and methods for the treatment of neurological disorders related to glutamate excitotoxicity and Amyloid β toxicity. More specifically, the present invention relates to novel combinatorial therapies of Multiple Sclerosis, Alzheimer's disease, Alzheimer's disease related disorders, Amyotrophic Lateral Sclerosis, Parkinson's disease, Huntington's disease, neuropathic pain, alcoholic neuropathy, alcoholism or alcohol withdrawal, or spinal cord injury.
Patent AU-2012254105-B2 (AU)
Title: Carton with article protection feature
Inventor: SCHMAL MICHAEL R
IPC: B65D71/34
Filed: 2012-03-14
Granted: 2016-02-25
Abstract: A carton for containing at least one article. The carton comprises at least one panel that can form an interior of the carton. The carton comprises at least one protection feature for protecting the articles from breakage. The article protection feature can comprise at least one feature in end flaps of the carton. The article protection feature can comprise an article protection flap foldably connected to the at least one panel. The article protection flap can be moveable between a first position and a second position wherein the article protection flap is folded relative to the at least one panel.
Patent AU-2012264899-B2 (AU)
Title: Cancer treatment by combining DNA molecules mimicking double strand breaks with hyperthermia
Inventor: DUTREIX MARIE
IPC: C12N15/115
Filed: 2012-05-25
Granted: 2016-04-21
Abstract: The present invention relates to a method for treating a cancer including a combination of a treatment by a nucleic acid molecule mimicking double strand breaks with hyperthermia.
Patent AU-2012268562-B2 (AU)
Title: Methods for reducing neurodegeneration
Inventor: MIDDLETON RONDO PAUL
IPC: A01N43/48
Filed: 2012-06-04
Granted: 2016-06-16
Abstract: The invention provides methods for reducing neurodegeneration in animals by administering a neurodegeneration reducing amount of melatonin to the animal. Generally, the melatonin is administered in amounts of either 0.1 ng/kg/day to about 10 mg/kg/day or from about 0.2 ng/day to about 3 g/day. In preferred methods, the melatonin is administered as part of a food composition.
Patent AU-2012269240-B2 (AU)
Title: Single unit chromatography antibody purification
Inventor: VEENSTRA HENDERIK E
IPC: C07K1/36
Filed: 2012-06-08
Granted: 2016-01-21
Abstract: The present invention relates to a method for the purification of antibodies from a protein mixture produced in a bioreactor, at least comprising the steps of intermediate purification and polishing, wherein the intermediate and polishing step comprises in-line anion exchange chromatography (AEX) treatment and mixed mode chromatography (MiMo) treatment in flow through mode. The present invention further relates to a single operational unit comprising both an anion exchange chromatography part and a mixed mode chromatography part, which are serially connected, wherein the unit comprises an inlet at the upstream end of the anion exchange chromatography part and an outlet at the downstream end of the mixed mode chromatography part and wherein the unit also comprises an inlet between the anion exchange chromatography part and the mixed mode chromatography part.
Patent AU-2012289492-B2 (AU)
Title: 2,3-dihydroimidazo[1,2-c] pyrimidin-5(1H)-one compounds use as Lp-PLA2 inhibitors
Inventor: WAN ZEHONG
IPC: C07D487/04
Filed: 2012-07-25
Granted: 2016-02-04
Abstract: Disclosed are 2,3-dihydroimidazo[1,2-c]pyrimidin-5(1H)-one compounds that inhibit Lp-PLA
Patent AU-2012302144-B2 (AU)
Title: Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
Inventor: DOMINGUEZ CELIA
IPC: C07D401/00
Filed: 2012-08-28
Granted: 2017-06-15
Abstract: Certain chemical entities are provided herein. Also provided are pharmaceutical compositions comprising at least one chemical entity and one or more pharmaceutically acceptable vehicle. Methods of treating patients suffering from certain diseases and disorders responsive to the inhibition of KMO activity are described, which comprise administering to such patients an amount of at least one chemical entity effective to reduce signs or symptoms of the disease or disorder are disclosed. These diseases include neurodegenerative disorders such as Huntington's disease. Also described are methods of treatment include administering at least one chemical entity as a single active agent or administering at least one chemical entity in combination with one or more other therapeutic agents. Also provided are methods for screening compounds capable of inhibiting KMO activity.
Patent AU-2012304174-B2 (AU)
Title: Methods and systems for the inversion of magnetic data from remnant and induced sources in geophysical exploration
Inventor: ELLIS ROBERT G
IPC: G01V3/38
Filed: 2012-08-28
Granted: 2014-11-06
Abstract: A method for modeling a subsurface anomalous magnetization zone including the steps of generating a magnetic field model of the subsurface anomalous magnetization zone, inverting the magnetic field model; and generating a model of the subsurface anomalous magnetization zone based on the inversion. The step of generating the magnetic field model include generating the magnetic field model from induced magnetization sources and remnant magnetization sources.
Patent AU-2012316941-B2 (AU)
Title: Novel compounds as HIF-1alphainhibitors and manufacturing process thereof
Inventor: LEE KYEONG
IPC: C07D241/04
Filed: 2012-09-27
Granted: 2016-02-25
Abstract: The present invention relates to novel compounds as HIF-1α inhibitors, manufacturing process thereof, and a pharmaceutical compositions. The compounds according to the present invention having inhibition activity against HIF-1α, can be used as a therapeutic prevention and/or treatment for various solid cancers such as colon cancer, liver cancer, stomach cancer and breast cancer. Also, the compounds according to the present invention are useful in the treatment of diabetic retinopathy and rheumatoid arthritis, which are aggravated by HIF-1α-mediated VEGFA expression.
Patent AU-2012322797-B2 (AU)
Title: Uses for and article of manufacture including HER2 dimerization inhibitor Pertuzumab
Inventor: ALAVATTAM SREEDHARA
IPC: A61K45/06
Filed: 2012-10-11
Granted: 2016-04-21
Abstract: The present application describes uses for and articles of manufacture including Pertuzumab, a first-in-class HER2 dimerization inhibitor. In particular, the application describes methods for extending progression free survival in a HER2-positive breast cancer patient population; combining two HER2 antibodies to treat HER2-positive cancer without increasing cardiac toxicity; treating early-stage HER2-positive breast cancer; treating HER2-positive cancer by co-administering a mixture of Pertuzumab and Trastuzumab from the same intravenous bag; treating HER2-positive metastatic gastric cancer; treating HER2-positive breast cancer with Pertuzumab, Trastuzumab and Vinorelbine; treating HER2-positive breast cancer with Pertuzumab, Trastuzumab and aromatase inhibitor; and treating low HER3 ovarian, primary peritoneal, or fallopian tube cancer. It also describes an article of manufacture comprising a vial with Pertuzumab therein and a package insert providing safety and/or efficacy data thereon; a method of making the article of manufacture; and a method of ensuring safe and effective use of Pertuzumab related thereto. In addition the application describes an intravenous (IV) bag containing a stable mixture of Pertuzumab and Trastuzumab suitable for administration to a cancer patient.
Patent AU-2012329208-B2 (AU)
Title: Treated inorganic pigments having improved dispersability and use thereof in paper products
Inventor: DIEBOLD MICHAEL PATRICK
IPC: C09C1/36
Filed: 2012-10-11
Granted: 2016-04-21
Abstract: The disclosure provides a laminate paper comprising a treated inorganic core particle, in particular treated titanium dioxide (TiO
Patent AU-2012355640-B2 (AU)
Title: Wireless relay module having emergency call functionality
Inventor: GAINES ROBERT B
IPC: H04W4/90
Filed: 2012-12-11
Granted: 2015-12-17
Abstract: A system for networked communications between a series of medical devices, wireless relay modules, and a remote device wireless relay network and an internet-accessible wireless communication network. At least one relay module includes a receiver, a first transmitter coupled to the wireless relay network, a second transmitter coupled to the internet-accessible wireless communication network, and a controller. The controller determines whether the internet- accessible wireless communications network is accessible. If accessible, then medical device data is transmitted to a remote device over that network using the second transmitter. If not accessible, then the first transmitter is used to transmit medical device data to another wireless relay module over the wireless relay network. Additionally, the controller analyzes the medical device data to determine whether an emergency condition exists, and transmits the medical device data to an emergency responder if such condition occurs together with location data for an associated medical device.
Patent AU-2012387503-B2 (AU)
Title: Use of PEDF-derived polypeptides for promoting muscle or tendon regeneration or arteriogenesis
Inventor: TSAO YEOU-PING
IPC: A61P21/00
Filed: 2012-08-09
Granted: 2016-11-03
Abstract: Provided is a synthetic peptide derived from PEDF, which has 20-39 amino acid residues. Also provided are pharmaceutical compositions containing the synthetic peptide and the use thereof. The peptide is useful in promoting muscle or tendon regeneration, and/or arteriogenesis in a subject.
Patent AU-2013201720-B2 (AU)
Title: Power System
Inventor: GELONESE DOMENICO
IPC: G06Q50/06
Filed: 2013-03-08
Granted: 2015-02-05
Abstract: A computer implemented system and method for demand management in an energy supply network including aggregation of energy use modification offers from energy consumers in order to meet value offers from energy suppliers,
Patent AU-2013201998-B2 (AU)
Title: Integrated self-fixating visualization devices, systems and methods
Inventor: STOPEK JOSHUA
IPC: A61B19/00
Filed: 2013-03-21
Granted: 2014-09-04
Abstract: INTEGRATED SELF-FIXATING VISUALIZATION DEVICES, SYSTEMS AND METHODS Surgical visualization devices (10) are provided which include a substrate (12) having at least one imaging device (18) and a plurality of fasteners (16) coupled thereto for attaching the substrate (12) to patient tissue. Systems and methods utilizing the surgical visualization devices (10) are also provided. ,-10
Patent AU-2013202356-B2 (AU)
Title: Compositions for lightening skin color
Inventor: MADISON STEPHEN ALAN
IPC: A61Q19/02
Filed: 2013-04-03
Granted: 2015-10-22
Abstract: COMPOSITIONS FOR LIGHTENING SKIN COLOR 5 Skin lightening additives and skin lightening compositions having at least one of a heterosubstituted, saturated or unsaturated aliphatic acid are described. The compositions are suitable for topical application and may comprise 12-hydroxystearic acid, ricinoleic acid or both.
Patent AU-2013205175-B2 (AU)
Title: Computer program products and methods for displaying digital looseleaf content
Inventor: WALLIS PETER DANIEL
IPC: G06F40/00
Filed: 2013-03-14
Granted: 2015-12-17
Abstract: 31547-213/LEN0045WO -27 Computer program products and methods for displaying information relating to one or more digital looseleafs are disclosed. In one embodiment, a computer program product includes a computer usable medium having computer readable instructions 5 embodied therein. The computer readable instructions cause a processor to display of a first table of contents page of a digital looseleaf. In response to receipt of a user selection of a representation of an individual one of the plurality of main sections, a second table of contents page is displayed overtop the first table of contents page such that an edge portion of the first table of contents page is unobstructed by the second table 10 of contents page. In response to receipt of a user input in the edge portion of the first table of contents page, an entirety of the first table of contents page is displayed.
Patent AU-2013211836-B2 (AU)
Title: Variable planform shelving system
Inventor: FANOURGIAKIS GEORGE
IPC: A47B46/00
Filed: 2013-01-28
Granted: 2016-05-19
Abstract: Variable planform shelving systems include a variable support platform and a support surface assembly that is supported by the variable support platform. The variable support platform includes frames that can be repositioned relative to each other to vary the planform of the variable support platform. The support surface assembly provides a support surface for supported items. The support surface assembly is flexible and/or comprised of a plurality of linked panels so that the support surface provided varies in response to variation in the planform of the variable support platform.